Mesoblast | MSB - Selling And Administration Expenses



Mesoblast reported 12.14M in Selling and Administration Expenses for its fiscal semester ending in June of 2024.


Selling And Administration Expenses Change Date
Avita Medical AUD 21.23M 2.57M Dec/2024
Clinuvel Pharmaceuticals AUD 16.21M 3.62M Jun/2024
Cochlear AUD 470M 4.4M Dec/2024
CSL USD 1.18B 201M Dec/2024
Pacific Edge NZD 19.43M 12.04M Sep/2024
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Starpharma Holdings AUD 3.13M 1.31M Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024